Pallas Capital Advisors LLC acquired a new position in agilon health, inc. (NYSE:AGL – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 11,028 shares of the company’s stock, valued at approximately $77,000.
A number of other institutional investors and hedge funds have also recently modified their holdings of AGL. J.Safra Asset Management Corp raised its stake in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares during the period. Quest Partners LLC purchased a new position in agilon health in the 4th quarter valued at approximately $45,000. Neo Ivy Capital Management purchased a new stake in agilon health during the 4th quarter worth about $47,000. CWM LLC lifted its holdings in shares of agilon health by 406.5% in the second quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares in the last quarter. Finally, Nisa Investment Advisors LLC bought a new position in shares of agilon health in the second quarter valued at approximately $60,000.
agilon health Stock Down 0.9 %
AGL traded down $0.04 during midday trading on Wednesday, reaching $4.59. The company’s stock had a trading volume of 299,534 shares, compared to its average volume of 5,044,015. The stock’s 50-day moving average is $6.29 and its 200-day moving average is $5.94. agilon health, inc. has a 1 year low of $4.41 and a 1 year high of $20.37. The firm has a market capitalization of $1.89 billion, a price-to-earnings ratio of -6.61 and a beta of 0.60. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.04.
Wall Street Analysts Forecast Growth
A number of analysts recently weighed in on AGL shares. Evercore ISI upped their target price on shares of agilon health from $5.50 to $7.00 and gave the stock an “in-line” rating in a report on Tuesday, July 9th. Deutsche Bank Aktiengesellschaft lowered their price target on agilon health from $5.00 to $4.00 and set a “hold” rating on the stock in a report on Friday, August 9th. Truist Financial boosted their price objective on agilon health from $6.40 to $6.50 and gave the stock a “hold” rating in a report on Friday, May 24th. Robert W. Baird began coverage on shares of agilon health in a research note on Thursday, May 30th. They issued a “neutral” rating and a $6.00 target price on the stock. Finally, Benchmark reissued a “buy” rating and issued a $9.00 price target on shares of agilon health in a research note on Thursday, August 8th. One investment analyst has rated the stock with a sell rating, fourteen have assigned a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, agilon health has an average rating of “Hold” and an average price target of $8.57.
View Our Latest Research Report on agilon health
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than agilon health
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Target Hits the Mark: Q2 Earnings Exceed Expectations
- What is a SEC Filing?
- Is Tesla’s Rebound Just Starting? Why You Should Consider Buying
- How to Use Stock Screeners to Find Stocks
- Stanley Druckenmiller’s Latest Bet: MELI—Should You Follow Suit?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.